Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the European Union (EU). Commercial availability of the IVDR-certified assay is anticipated by early April 2026. The IVDR replaces the former In Vitro Diagnostics Directive (IVDD), introducing significantly more stringent requirements for clinical evidenc...

CUSP Wealth, an investment firm regulated by the DFSA, details how its hybrid advisory model combines AI-driven portfolio optimisation with on-demand access to experienced financial advisors - enabling institutional-grade wealth advisory at 0.75% annual fees, a fraction of traditional costs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260325272893/en/AI & Human Synergy Advisory Model by CUSP Wealth (Photo: AETOSWire) "No one ...